Active substances

Zalcitabine›

J05AF03 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Indicated for: HIV-1 infection

Zaleplone›

N05CF03 Nervous system | Hypnotics and sedatives | Benzodiazepine related drugs

Indicated for: insomnia

Zanamivir›

J05AH01 Antiinfectives for systemic use | Direct acting antivirals | Neuraminidase inhibitors

Indicated for: influenza

Zanubrutinib›

L01EL03 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Bruton's tyrosine kinase (BTK) inhibitors

Indicated for: hematologic malignancies

Ziconotide›

N02BG08 Nervous system | Other analgesics and antipyretics

Indicated for: moderate to severe pain

Zidovudine›

J05AF01 Antiinfectives for systemic use | Direct acting antivirals | Nucleoside and nucleotide reverse transcriptase inhibitors

Indicated for: HIV-1 infection

Zilucoplan›

L04AJ06 Antineoplastic and immunomodulating agents | Immunosuppressants | Immunosuppressants | Complement inhibitors

Indicated for: myasthenia gravis

Zinc acetate›

A16AX05 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: mineral deficiency; mineral supplementation

Zinc acetate dihydrate›

A16AX05 Alimentary tract and metabolism | Other alimentary tract and metabolism products | Other alimentary tract and metabolism products | Various alimentary tract and metabolism products

Indicated for: Wilson disease

Zinc bacitracin + neomycin›

D06AX04 Dermatologicals | Antibiotics for topical use | Other antibiotics for topical use

Indicated for: bacterial infections

Zinc orotate›

A12CB Alimentary tract and metabolism | Other mineral supplements | Zinc

Indicated for: mineral deficiency; mineral supplementation

Zinc sulphate + benzalkonium chloride›

S01AX03 Sensory organs | Antiinfectives | Other antiinfectives

Indicated for: superficial wounds; local antisepsis

Ziprasidone›

N05AE04 Nervous system | Antipsychotics | Indole derivatives

Indicated for: schizophrenia; bipolar disorder

Zofenopril›

C09AA15 Cardiovascular system | Ace inhibitors, plain

Indicated for: hypertension

Zofenopril + hydrochlorothiazide›

C09BA15 Cardiovascular system | Ace inhibitors, combinations | Ace inhibitors and diuretics

Indicated for: hypertension

Zolbetuximab›

L01FX31 Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Other monoclonal antibodies and antibody drug conjugates

Indicated for: cancer

Zoledronic acid›

M05BA08 Musculo-skeletal system | Drugs affecting bone structure and mineralization | Bisphosphonates

Indicated for: osteoporosis; bone metastases; tumor-induced hypercalcemia

Zolmitriptan›

N02CC03 Nervous system | Antimigraine preparations | Selective serotonin (5HT1) agonists

Indicated for: migraine

Zolpidem›

N05CF02 Nervous system | Hypnotics and sedatives | Benzodiazepine related drugs

Indicated for: insomnia

Zonisamide›

N03AX15 Nervous system | Antiepileptics | Antiepileptics | Other antiepileptics

Indicated for: epilepsy

Zopiclone›

N05CF01 Nervous system | Hypnotics and sedatives | Benzodiazepine related drugs

Indicated for: insomnia

Zoster vaccine›

J07BK02 Antiinfectives for systemic use | Viral vaccines | Varicella zoster vaccines

Indicated for: prevention of herpes zoster

Zotepine›

N05AX11 Nervous system | Antipsychotics | Other antipsychotics

Indicated for: schizophrenia; bipolar disorder

Zuclopenthixol›

N05AF05 Nervous system | Antipsychotics | Thioxanthene derivatives

Indicated for: schizophrenia; bipolar disorder